Feb 25, 2025
Alzheimer’s disease is more than just memory loss—it’s a progressive neurodegenerative disorder that slowly erodes cognition, behavior, and independence. What may begin as occasional forgetfulness or difficulty recalling names can soon escalate into disorientation, personality changes, and an inability to carry out...
Read More...
Dec 13, 2019
AI-driven treatment approach and growing Fragile X Syndrome market size Healx Pharma has recently partnered with Boehringer Ingelheim to advance the treatment market and invest in R&D related to rare neurological disorders. Under the deal signed, Healx Artificial Intelligence (AI) drug discovery platfo...
Read More...
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Newsletter/Whitepaper